
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/">
  <dc:date>2025</dc:date>
  <dc:type>info:eu-repo/semantics/conferenceProceedings</dc:type>
  <dc:identifier>https://phaidrabg.bg.ac.rs/o:36611</dc:identifier>
  <dc:identifier>doi:10.46793/ICCBIKG25.292D</dc:identifier>
  <dc:title xml:lang="eng">Bioinformatics analysis of microRNAs derived from HTR-8SVneo potentially  targeting BCL2 in ovarian cancer cell line A2780 </dc:title>
  <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode</dc:rights>
  <dc:creator id="https://orcid.org/0000-0002-4652-7719">Dobrijević, Zorana</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-6104-693X">Goč, Sanja</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-6170-1826">Vuković, Jovana</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-1182-4895">Pirković, Andrea</dc:creator>
  <dc:description xml:lang="eng">Our recent study demonstrated the ameliorative effect of extracellular vesicles (EVs) 
from trophoblast cells (TC-EVs) on ovarian cancer (OC) A2780 cells’ sensitivity to cisplatin, likely 
via modulation of pro-apoptotic pathways. However, the mechanisms and the exact constituents 
of EVs which display pro-apoptotic effect in recipient cells remain unclear. The aim of this study 
is to investigate via in silico analysis whether microRNAs present in TC-EVs produced by HTR
8/SVneo cells could mediate the observed pro-apoptotic effect in OC and exert other cancer 
phenotype-related mechanisms. MicroRNA profiling results of TC-EVs were extracted from GEO 
dataset GSE182717 and microRNAs were ranked according to normalized read counts. Among 75 microRNAs presented with average rpm≥1000, 30 were identified as BCL2 regulators. After the exclusion of microRNAs highly expressed in recipient A2780 cells, microRNA-mRNA network 
topology analysis identified 11 hub TC-EVs-abundant microRNAs. Gene ontology (GO) analyses 
indicated that potential targets of these hub microRNA genes were concentrated predominantly 
on “MAPKKK activity”, “regulation of DNA-dependent transcription, elongation” and “ligase 
activity, forming carbon-oxygen” (molecular function category), while most hits belonged to 
“Pathways in cancer” and “MAPK signaling pathway”. Prioritizing of potential candidates for 
future experimental validation relied on identifying hits for the most abundant TC-EVs BCL2
targeting microRNAs within a panel of downregulated microRNAs from cisplatin resistant OC 
cell lines (GSE1617848) and literature-supported effects on BCL2 expression in OC. The most 
plausible candidate for TC-EVs-A2780 delivery analysis was found to be miR-16-5p. The 
presented results illustrate the potential relation between the delivery of TC-EVs microRNAs and 
apoptotic pathway activation in A2780. Additional findings on TC-EVs microRNA functions and 
candidate microRNA delivery are required for further interpretation of the contributing effect of 
microRNAs on experimentally observed changes in TC-EVs-treated A2780 cells.</dc:description>
  <dc:source>Bioinformatics analysis of microRNAs derived from HTR-8/SVneo potentially targeting BCL2 in ovarian cancer cell line A2780</dc:source>
  <dc:source>startpage: 294</dc:source>
  <dc:source>endpage: 297</dc:source>
  <dc:subject xml:lang="eng">ovarian cancer, trophoblast, microRNA, extracellular vesicles</dc:subject>
  <dc:language>eng</dc:language>
  <dc:publisher>Institut za informacione tehnologije, Univerzitet u Kragujevcu, Srbija</dc:publisher>
  <dc:format>application/pdf</dc:format>
  <dc:format>8382490 bytes</dc:format>
</oai_dc:dc>
